Inventor
SALEEM AHMAD
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes29%
PatentTitleYear
12,492,186Bicyclic heterocyclic compounds useful as IRAK4 inhibitors202512,421,230Tricyclic heteroaryl compounds useful as IRAK4 inhibitors202512,391,702Benzo[5,6][1,4]dioxino[2,3-b]pyridine compounds useful as IRAK4 inhibitors202512,304,916Thienopyridinyl and thiazolopyridinyl compounds useful as IRAK4 inhibitors202511,623,921Indole carboxamide compounds202311,479,538Tetrazolone-substituted dihydropyridinone MGAT2 inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to BRISTOL MYERS SQUIBB CO (6)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 6 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2025 |